Emerging clinical concerns in the ageing haemophilia patient

The availability of safe replacement clotting factor concentrates together with effective antiviral drugs to treat human immunodeficiency and hepatitis C viruses and the provision of care at designated haemophilia treatment centres have resulted in a new phenomenon in haemophilia management – the ag...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haemophilia : the official journal of the World Federation of Hemophilia 2009-11, Vol.15 (6), p.1197-1209
Hauptverfasser:	KONKLE, B. A., KESSLER, C., ALEDORT, L., ANDERSEN, J., FOGARTY, P., KOUIDES, P., QUON, D., RAGNI, M., ZAKARIJA, A., EWENSTEIN, B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged ageing Blood Coagulation Factors - therapeutic use Cardiovascular Diseases - complications Cardiovascular Diseases - drug therapy Cardiovascular Diseases - epidemiology comorbidities Comorbidity Factor VIII - therapeutic use haemophilia Hemophilia A - complications Hemophilia A - drug therapy Hemophilia A - epidemiology Humans Joint Diseases - complications Joint Diseases - drug therapy Joint Diseases - epidemiology Kidney Failure, Chronic - complications Kidney Failure, Chronic - drug therapy Kidney Failure, Chronic - epidemiology Liver Diseases - complications Liver Diseases - drug therapy Liver Diseases - epidemiology Male Middle Aged Neoplasms - complications Neoplasms - drug therapy Neoplasms - epidemiology Practice Guidelines as Topic Risk Assessment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!